Barcelona, Spain
The final PRISM2 Meeting will be held from 05 – 07 November 2024.
Social dysfunction is associated with altered facial emotion neural processing across diverse neuropsychiatric disorders
Identifying biology-driven psychiatric drug target genes in the context of neuronal circuits
Transdiagnostic biomarkers of allocentric spatial navigation in Alzheimer’s disease and schizophrenia: PRISM 1 study results
Social dysfunction relates to transdiagnostic shifts within socioaffective brain systems among schizophrenia and Alzheimer’s disease patients
7th SC meeting
Leiden, Netherlands
The seventh PRISM² SC meeting will be held from 29 – 30 May 2024.
Perspectives on PRISM – Interview with Mirthe Ronde and Bastian Hengerer
Mirthe Ronde and Bastian Hengerer were interviewed by ECNP Press Officer Tom Parkhill about their back-translational work and its role in the Prism2 project.
Click here to read the full interview.
The human neuropsychiatric risk gene Drd2 is necessary for social functioning across evolutionary distant species
Digital behavioural signatures reveal trans-diagnostic clusters of Schizophrenia and Alzheimer’s disease patients
PRISM, RDoC, and neuropsychiatric diseases – Interview with Dr Bruce Cuthbert
Dr Cuthbert recently spoke to ECNP press officer Tom Parkhill about RDoC, PRISM, and the future of research into the causes and treatment of mental health issues.
Click here to read the full interview.
